Skip to content

Feasibility Study: Sleuth Monitoring System

Pilot Clinical Study of the Sleuth Implantable ECG Monitoring System

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00719277
Acronym
PULSE
Enrollment
40
Registered
2008-07-21
Start date
2006-12-31
Completion date
2009-09-30
Last updated
2009-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Syncope

Keywords

cardiac arrhythmia, syncope, ECG, implantable ECG monitor, ILR

Brief summary

The purpose of the study is to evaluate the safety and performance of the Sleuth Monitoring system.

Interventions

DEVICESleuth Implantable ECG Monitoring System

The study device provides monitoring only. It cannot provide intervention or treatment.

Sponsors

Transoma Medical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> = 18 years at time of enrollment * Either of the following: 1. MI \> 30 days prior to enrolment and LVEF \< = 35% by echocardiography (or nuclear imaging as necessary) 2. Syncope of unknown etiology

Exclusion criteria

* Life expectancy \< 12 months following enrollment * Active infection

Design outcomes

Primary

MeasureTime frame
Diagnostically viable ECG signalsdaily

Secondary

MeasureTime frame
rate of device-related adverse events1, 6, and 12 months

Countries

Panama

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026